Abuse- Deterrent Formulations of Opioid Analgesics

被引:10
作者
Pergolizzi, Joseph V., Jr. [1 ,2 ,3 ]
LeQuang, Jo Ann [1 ,4 ]
机构
[1] Assoc Chron Pain Patients, Houston, TX 77401 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[3] Georgetown Univ, Sch Med, Dept Med, Washington, DC USA
[4] NEMA Res Inc, Naples, FL USA
关键词
PRESCRIPTION; PSYCHOMOTOR; OXYCODONE;
D O I
10.1111/papr.12093
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
引用
收藏
页码:204 / 206
页数:3
相关论文
共 15 条
[1]   Geographic information systems and pharmacoepidemiology: using spatial cluster detection to monitor local patterns of prescription opioid abuse [J].
Brownstein, John S. ;
Green, Traci C. ;
Cassidy, Theresa A. ;
Butler, Stephen F. .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (06) :627-637
[2]   Can abuse deterrent formulations make a difference? Expectation and speculation [J].
Budman, Simon H. ;
Serrano, Jill M. Grimes ;
Butler, Stephen F. .
HARM REDUCTION JOURNAL, 2009, 6
[3]   Development and validation of an Opioid Attractiveness Scale: A novel measure of the attractiveness of opioid products to potential abusers [J].
Butler S.F. ;
Benoit C. ;
Budman S.H. ;
Fernandez K.C. ;
McCormick C. ;
Venuti S.W. ;
Katz N. .
Harm Reduction Journal, 3 (1)
[4]   Internet surveillance: Content analysis and monitoring of product-specific Internet prescription opioid abuse-related postings [J].
Butler, Stephen F. ;
Venuti, Synne Wing ;
Benoit, Christine ;
Beaulaurier, Richard L. ;
Houle, Brian ;
Katz, Nathaniel .
CLINICAL JOURNAL OF PAIN, 2007, 23 (07) :619-628
[5]   Measuring Attractiveness for Abuse of Prescription Opioids [J].
Butler, Stephen F. ;
Fernandez, Kathrine C. ;
Chang, Alan ;
Benoit, Christine ;
Morey, Leslie C. ;
Black, Ryan ;
Katz, Nathaniel .
PAIN MEDICINE, 2010, 11 (01) :67-80
[6]   An iterative model for in vitro laboratory assessment of tamper deterrent formulations [J].
Cone, Edward J. ;
Giordano, Jennifer ;
Weingarten, Brianne .
DRUG AND ALCOHOL DEPENDENCE, 2013, 131 (1-2) :100-105
[7]   The ageing heroin user: Career length, clinical profile and outcomes across 36 months [J].
Darke, Shane ;
Mills, Katherine L. ;
Ross, Joanne ;
Williamson, Anna ;
Havard, Alys ;
Teesson, Maree .
DRUG AND ALCOHOL REVIEW, 2009, 28 (03) :243-249
[8]  
Food and Drug Administration, 2013, GUID IND AB DET OP E
[9]   Challenges in the development of prescription opioid abuse-deterrent formulations [J].
Katz, Nathaniel P. ;
Adams, Edgar H. ;
Chilcoat, Howard ;
Colucci, Robert D. ;
Comer, Sandra D. ;
Goliber, Philip ;
Grudzinskas, Charles ;
Jasinski, Donald ;
Lande, Stephen D. ;
Passik, Steven D. ;
Schnoll, Sidney H. ;
Sellers, Edward ;
Travers, Debra ;
Weiss, Roger .
CLINICAL JOURNAL OF PAIN, 2007, 23 (08) :648-660
[10]  
Pergolizzi JV, 2012, CURR PHARM DESIGN, V18, P6109